ArticleBiotechnology progress
Mechanistic deconvolution of BSA size variants by constrained Raman pseudo-Voigt hard modeling during anion-exchange chromatography.
Article in Biotechnology progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In biopharmaceutical manufacturing, protein aggregation is a critical quality attribute, necessitating rapid and reliable analytical strategies during downstream processes like anion-exchange chromatography (AEX). While Raman spectroscopy enables continuous monitoring of protein secondary structure, standard data-driven regression models struggle to decouple intrinsic structural changes from gradient-induced solvent and buffer drifts under dynamic chromatographic conditions. Addressing this methodological gap, this study establishes a constrained pseudo-Voigt hard modeling framework for the mechanistic deconvolution of bovine serum albumin (BSA) size variants during in-line Raman monitoring of AEX processes. By explicitly defining a parametric background model to capture salt-induced spectral drift, the methodology effectively isolates matrix variations from genuine protein-specific signals. The constrained hard model was applied to 285 in-line spectra across diverse chromatographic conditions, achieving reconstruction fidelity while maintaining stable, physically interpretable component identities. The mechanistically derived Amide I center of mass emerged as a robust, aggregation-sensitive descriptor that preserves structural information despite strong concentration dynamics. Furthermore, the extracted spectral features demonstrated strong predictive performance for monomer concentration and acceptable accuracy for high molecular weight components. Collectively, these results demonstrate that constrained spectral hard modeling provides a highly interpretable, robust, and calibration-light alternative to classical partial least squares approaches for the real-time monitoring of protein size variants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.